Chemed (CHE) Cash & Equivalents (2009 - 2026)

Chemed's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 90.31% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (down 90.31% YoY), while the FY2025 annual figure was $74.5 million, down 58.22% from the prior year.
• Cash & Equivalents was $16.9 million for Q1 2026 at Chemed, down from $74.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $313.3 million in Q1 2024 to a low of $7.8 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $139.0 million across 5 years, with a median of $159.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 91.36% in 2022, then surged 2125.29% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $74.1 million in 2022, then surged by 256.09% to $264.0 million in 2023, then plunged by 32.43% to $178.4 million in 2024, then sank by 58.22% to $74.5 million in 2025, then plunged by 77.38% to $16.9 million in 2026.
• The last three Cash & Equivalents figures came in at $16.9 million (Q1 2026), $74.5 million (Q4 2025), and $129.8 million (Q3 2025), per Business Quant data.